Optometrists in Houston, MO Accepting Medicare
3 Optometrists found. Showing 1 - 3
 Ream Optometry Optometrist Medicare: Not Enrolled in Medicare Practice Location: 112 W Pine St, Houston, MO 65483 Phone: 417-967-4090 Fax: 417-967-4091 |
 Dr. Angela Jo Holden, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1433 S Sam Houston Blvd, Houston, MO 65483 Phone: 417-967-1868 Fax: 417-967-1870 |
Angela Holden Od Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1433 S Sam Houston Blvd, Houston, MO 65483 Phone: 417-967-1868 Fax: 417-967-1870 |
News Archive
Eating more fruit and vegetables can boost people's happiness levels
University of Warwick research indicates that eating more fruit and vegetables can substantially increase people's later happiness levels.
Study reveals frequent use of coercive measures in Finnish psychiatric care
The use of coercive measures in psychiatric care has decreased over the past years. However, a new study shows that coercive measures are still frequently used in Finland, and periods of both seclusion and mechanical restraint are long.
BioTime amends license agreement with University of Utah for HyStem technology
BioTime, Inc. announced that the company has amended its license from the University of Utah to expand the field of use for which BioTime is licensed to produce and market products covered by the core patents underlying HyStem technology.
Use of lubricants with anal sex associated with increased risk of rectal sexually transmitted infections
The risk of acquiring HIV through unprotected anal sex is at least 20 times greater than with unprotected vaginal sex and increases if other infections are already present in the rectal lining. Could the use of lubricants - at least certain kinds - be another risk factor among men and women who engage in receptive anal intercourse? Two studies presented today at the International Microbicides Conference in Pittsburgh, suggest the answer is yes.
IRX Therapeutics and Japan's NCRC collaborate to evaluate peptide-based cancer vaccines
IRX Therapeutics, a developer of novel immunomodulators to treat cancer and viral diseases, today announced that it has established a strategic collaboration with Japan's National Cancer Research Center (NCRC) to evaluate next-generation peptide-based cancer vaccines. Clinical research will be conducted at NCRC. IRX Therapeutics will provide its proprietary IRX-2 immunomodulatory regimen, clinical trial design and technical support. This is the first collaboration of its kind between the NCRC and a U.S.-based biotechnology firm.
› Verified 8 days ago
Speech-Language Pathologists
Chiropractors
Optometrists
Physical Therapists